Clinical Trial Supplies Market Analysis by Different Segments

By Products and Services

• Manufacturing
• Packaging and Labeling
• Logistics and Distribution

By Phase

• Phase I
• Phase II
• Phase III

By Therapeutic Area

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS And Mental Disorders
• Dermatology
• Blood Disorders
• Infectious Diseases
• Others.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172240059

The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1%. 

The global market is broadly classified into manufacturing services, packaging and labeling services, and logistics and distribution services. The logistics and distribution segment is expected to account for the largest share of the global clinical trial supplies products market in 2015.

The major players in the market are Alamc Group LTD (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), Biocair (U.K.), and Thermo Fisher Scientific, Inc. (U.S.).

To Know More @ https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html

Point of Care Molecular Diagnostics Market Growing at a CAGR of 14.7%

The global point of care molecular diagnostics market was valued at USD 632.5 Million in 2017 and is projected to reach USD 1,440.2 Million in 2023, at a CAGR of 14.7%

The scope of the study includes POC molecular diagnostics analyzers and assays that enable healthcare professionals in the detection of diseases through molecular technologies in point-of-care settings. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=143524127

The key players in the global Point of care molecular diagnostics market are, Roche Diagnostics (Switzerland), Biomerieux (France), Danaher (US), Abbott Laboratories (US), Quidel (US) and Meridian Bioscience (US).

Target Audience:

• POC Molecular Diagnostics Manufacturers
• Physicians
• Research Institutes
• Diagnostics Suppliers
• Market Research and Consulting Firms
• Regulatory Bodies
• Venture Capitalists

The POC molecular diagnostics market is segmented into RT-PCR, INAAT, and others technologies. In 2018, the RT-PCR segment is expected to account for the largest share of the global POC molecular diagnostics market. 

The large share of this segment can be attributed to the growing use of RT-PCR in proteomics and genomics and access to portable, easy-to-use devices. In the last three years from 2015, more than 42 RT-PCR based products have been launched for various diseases.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html

Patient Portal Market : Growth Opportunities | Market Analysis | Business Strategies

The patient portal market is projected to reach USD 2.74 Billion by 2020 from USD 1.19 Billion in 2015, at a CAGR of 18.1% during the forecast period.

Patient portals are an important form of patient engagement solutions that are gaining popularity across the globe. The use of health information technologies and online resources in healthcare boosts care quality by improving care access, efficiency, chronic disease management, and patient & family involvement.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49094801

 The growth of the overall patient portals market can be contributed to the federal mandates like meaning use, growing patient centric approach in healthcare delivery, increasing EHR adoption rate, and growing popularity of patient portals among the elderly. 

On the other hand, data security & privacy concerns, high cost of deployment of patient portal solutions, and requirement of infrastructural investments to support patient portals are some of the factors expected to restrain the growth of the market to a certain extent.

Target Audience:

• Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Pharmacies, Ambulatory Centers and Outpatient Clinics)
• Healthcare Insurance Companies/Payers
• Healthcare IT Service Providers
• Venture Capitalists
• Corporate Entities
• Accountable Care Organizations

Allscripts Healthcare Solutions, Inc. (U.S.), McKesson Corporation (U.S.), athenahealth, Inc. (U.S.), Cerner Corporation (U.S.), eClinicalWorks (U.S.), CureMD (U.S.), NextGen Healthcare Information Systems, LLC (U.S.), Greenway Health, LLC (U.S.), Medfusion (U.S.), Epic Corporation Inc. (U.S.), GE Healthcare (U.K.), and Intelichart (U.S.) are some of the key players in the patient portal market.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/patient-portal-market-49094801.html

Future of Oligonucleotide Synthesis Market Global Forecast to 2022

The growth of this market is mainly driven by the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.

The global oligonucleotide synthesis market is valued at USD 1.33 Billion in 2016 and is projected to reach USD 2.46 Billion by 2022, at a CAGR of 10.9%. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350

This report segments the market into product, application, end user, and region

Target Audience for this Report:

• Life science instrumentation and reagent companies
• Pharmaceutical and biotechnology companies
• Hospitals and clinics
• Academic researchers and government research organizations
• Private research institutes
• Custom oligonucleotide service providers
• Contract manufacturing organizations (CMOs)
• Oligonucleotide equipment manufacturers
• Contract research organizations (CROs)
• Market research and consulting firms
• Venture capitalists

The oligonucleotide synthesis market is highly competitive with the presence of several small and big players. 

Prominent players in the market include Integrated DNA Technologies (IDT) (US), Sigma-Aldrich Corporation (US) (part of Merck KGaA), Eurogentec (Belgium), Eurofins Genomics (Germany), Agilent Technologies (US), Thermo Fisher Scientific (US), BioAutomation (US), LGC Biosearch Technologies (US), GeneDesign (Japan), GE Healthcare (US), TriLink BioTechnologies (US), GenScript (China), Nitto Denko Avecia (US), ATDBio (UK), Bio-Synthesis (US), IBA GmbH (Germany), Gene Link (US), and AITbiotech Pte. (Singapore)

To Know More @ https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-200829350.html

Market Dynamics of Bioabsorbable Stents Market in Upcoming Years

Drivers

• Rapidly Growing Geriatric Population and Increased Risk of CAD and PAD in the Elderly

• Strong Product Pipeline

Restraints

• Presence of Substitutes

Opportunities

• Emerging Markets to Offer High-Growth Opportunities for Market PartiCIPAnts

Challenges

• Product Withdrawals and Failures

• High Risk of Complications

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40983380

Geographically, the Bioabsorbable Stents Market is dominated by Europe, followed by North America. North American market is expected to grow at the highest CAGR of 46.1% during the forecast period. This growth can be attributed to due to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.

The bioabsorbable stent market has fewer numbers of players. Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India) among others.

To Know More @ https://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.html

Market Analysis & Opportunities of Atherectomy Devices Market by Region

Geographically, atherectomy devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. 

The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers

.North America is expected to account for the largest share of the market in 2017, followed by Europe. Factors such as increasing availability of reimbursements for atherectomy devices, growing adoption of atherectomy devices among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials are driving the growth of the North American atherectomy devices market.

 However, Asia Pacific is expected to register the highest growth rate during the forecast period. This can be attributed to the increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems (less revascularization rates, high efficacy, short procedural time).

Stakeholders

• Original equipment manufacturers (OEMs)
• Product sales and distribution companies
• Healthcare service providers (hospitals and surgical centers)
• Non-government organizations
• Government regulatory authorities
• Research laboratories and academic institutes
• Clinical research organizations (CROs)
• Research and development companies
• Market research and consulting firms

To Know More, Speak to Our Expert @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=133112140